跳至主要内容
临床试验/NCT05380817
NCT05380817Unknown不适用

Stanford Kids Continuous Advanced Metabolic Profiling (CAMP) Study

Stanford University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Percentage of underrepresented minority participants enrolled

研究概览

简要总结

The Stanford Kids CAMP study aims to evaluate the feasibility of enrolling minority participants in school age children (5-13 years old) in a community summer camp setting along with the efficiency by which each participant's biologic specimens are collected. Using remote monitoring technologies and through partnering with community-based organizations, the investigators hypothesize that an increase in underrepresented minority participation in a clinical trial that is greater than the national average is possible.

详细描述

The proposed study is an outpatient prospective, open-label clinical trial comparing 2 groups: Group 1 (aka BAWSI Camp): the Dexcom G6 Pro Continuous Glucose Monitor and the accelerometer and mobile connected device, Group 2 (aka YMCA of Silicon Valley Camp): the Abbott FreeStyle Libre 2 Continuous Glucose Monitor and the accelerometer and mobile connected device. Eligible subjects will be enrolled to each cohort based on their participation in the specific YMCA camp site.

The investigators will study up to 100 minority school-age children (5 - 13 years old) in the San Francisco Bay Area a 5-day summer camp. The study will be split in 2 sequential phases: (A) the BAWSI camp, (B) the YMCA of Silicon Valley camp, following a repeated measures design with the 5-day camp being followed by 5 - 9 days at home, under parental supervision. Study participants will be divided in two equal groups at each site with each wearing the specific manufacturers continuous glucose monitoring device.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
5 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 5-13 years of age.
  • Avoidance of acetaminophen-containing medications (i.e. Tylenol) while wearing the continuous glucose monitor.
  • Willingness to wear a continuous glucose sensor and physiological monitor for the duration of the study.
  • A parent/caregiver is available for system training and will commit to be the main responsible person for the use of the monitoring system at home.

排除标准

  • Have a condition limiting their participation in the interventions (e.g., unable to participate in routine physical education classes at school, requiring oxygen supplementation for exertion, developmental or physical disability preventing participation in interventions, children or parents/guardians who cannot medically participate in mild dietary restrictions and/or increased physical activity for any reason).
  • Have a condition limiting participation in the assessments (child or primary caregiver not able to read surveys in English or Spanish, child two or more grade levels delayed in school for reading and writing in her native language).
  • Are unable to read, understand or complete informed consent in English or Spanish.
  • Are deemed to have another characteristic that makes them unsuitable for participation in the study in the judgment of the Principal Investigators.

结局指标

主要结局

Percentage of underrepresented minority participants enrolled

时间窗: Baseline (prior to arrival at camp)

Percentage of underrepresented minority participants enrolled compared to the U.S. national average.

次要结局

  • At-home urine specimen collection(Visit 1, Visit 3 (collected on days 1 and 5))
  • Continuous patient monitoring performance(Baseline through Visit 6 (days 1 though 14))
  • Duration of initial participant screening(Visit 1 (day 1, up to 60 minutes for screening))
  • Report of issues and concerns during at-home monitoring period(Visit 4, Visit 6 (days 6 and 14, up to 30 minutes to complete survey))
  • Physical activity measured by accelerometry(Baseline through Visit 6 (days 1 through 14))
  • Participant perceived use of study technology(Visit 6 (day 14, up to 15 minutes to complete survey))
  • Number of patient reported device related issues(Visit 1, Visit 2, Visit 3 (days 1 though 5))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karl Sylvester

Associate Dean Maternal Child Health - Research, Professor of Surgery

Stanford University

研究点 (2)

Loading locations...

相似试验